These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 1688295)
1. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions. Kletzel M; Beck S; Elser J; Shock N; Burks W Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295 [TBL] [Abstract][Full Text] [Related]
2. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071 [TBL] [Abstract][Full Text] [Related]
3. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome. Kalanadhabhatta V; Muppidi D; Sahni H; Robles A; Kramer M Ann Allergy Asthma Immunol; 1996 Nov; 77(5):394-400. PubMed ID: 8933778 [TBL] [Abstract][Full Text] [Related]
4. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus. Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079 [No Abstract] [Full Text] [Related]
5. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients. Absar N; Daneshvar H; Beall G J Allergy Clin Immunol; 1994 Jun; 93(6):1001-5. PubMed ID: 8006304 [TBL] [Abstract][Full Text] [Related]
6. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Gluckstein D; Ruskin J Clin Infect Dis; 1995 Apr; 20(4):849-53. PubMed ID: 7795084 [TBL] [Abstract][Full Text] [Related]
7. Trimethoprim-sulphamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions. Dis Markers; 1991; 9(6):355. PubMed ID: 1823331 [No Abstract] [Full Text] [Related]
9. Efficacy of primary chemoprophylaxis against Pneumocystis carinii pneumonia during the first year of life in infants infected with human immunodeficiency virus type 1. Rigaud M; Pollack H; Leibovitz E; Kim M; Persaud D; Kaul A; Lawrence R; John DD; Borkowsky W; Krasinski K J Pediatr; 1994 Sep; 125(3):476-80. PubMed ID: 7915306 [TBL] [Abstract][Full Text] [Related]
10. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598 [TBL] [Abstract][Full Text] [Related]
11. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient. Cook DE; Kossey JL Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811 [TBL] [Abstract][Full Text] [Related]
12. Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl. Gómez-Traseira C; Boyano-Martínez T; Escosa-García L; Pedrosa M; Martín-Muñoz F; Quirce S Pediatr Allergy Immunol; 2015 May; 26(3):287-289. PubMed ID: 25692246 [No Abstract] [Full Text] [Related]
13. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145 [TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. Carr A; Swanson C; Penny R; Cooper DA J Infect Dis; 1993 Jan; 167(1):180-5. PubMed ID: 8380290 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. Kovacs JA; Masur H Clin Infect Dis; 1992 May; 14(5):1005-9. PubMed ID: 1350925 [TBL] [Abstract][Full Text] [Related]
17. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Jung AC; Paauw DS Arch Intern Med; 1994 Nov; 154(21):2402-6. PubMed ID: 7979835 [TBL] [Abstract][Full Text] [Related]
18. A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient infected with the human immunodeficiency virus. Martin GJ; Paparello SF; Decker CF Clin Infect Dis; 1993 Jan; 16(1):175-6. PubMed ID: 8448303 [No Abstract] [Full Text] [Related]
19. Cutaneous adverse reactions and CD4+ cell counts in human immunodeficiency virus-infected patients receiving trimethoprim-sulfamethoxazole. Caumes E Clin Infect Dis; 1998 Feb; 26(2):530-2. PubMed ID: 9502502 [No Abstract] [Full Text] [Related]
20. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection. Belchi-Hernandez J; Espinosa-Parra FJ Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]